VB
VBIO
Valion Bio, Inc.
$0.5660
-5.67%
$1.8M
No data for this timeframe.
Vol
Market Cap$1.8M
Cap SizeNano Cap
Inst. Holders2 funds
Inst. Value$52.5K
Inst. Activity1 buys / 0 sells
Reddit Sentiment57° Neutral
SEC Reports2
Recent Activity
Jun 3, 2026
SEC
Valion Bio held its 2026 annual meeting on May 28, 2026. Shareholders approved an amendment to the 2021 Equity Incentive
8-K — Impact 2/10
May 18, 2026
Insider
Handley Michael K acquired via exercise 2,206 shares
Chief Executive Officer
May 14, 2026
SEC
Valion Bio (VBIO) reported Q1 2026 results, its first full quarter post-transformation from Tivic Health. Net loss widen
8-K — Impact 6/10
May 1, 2026
Insider
Lackey Melinda was granted 45,000 shares
General Counsel & SVP of Legal
Inst.
Marex Group plc — ADD
59,263 shares ($52.5K)
Inst.
BANK OF AMERICA CORP — ADD
13 shares ($19.00)
Latest Reports
NEUTRAL
8-K
2/10
Valion Bio held its 2026 annual meeting on May 28, 2026. Shareholders approved an amendment to the 2021 Equity Incentive
Jun 3, 2026
BEARISH
8-K
6/10
Valion Bio (VBIO) reported Q1 2026 results, its first full quarter post-transformation from Tivic Health. Net loss widen
May 14, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Marex Group plc | $52.5K | ADD |
| HRT FINANCIAL LP | $37.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 18, 2026 | Handley Michael | M | $0.00 |
| May 1, 2026 | Lackey Melinda | A | $0.00 |
Reddit Sentiment
57°
Neutral
Bearish
Neutral
Bullish
2 institutional holders with $52.5K total value (101,682 shares) as of 2026-Q1. Top holders: Marex, HRT. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Marex Group plc | 59,263 | $52.5K | 99.9% | ADD +44.7% |
| 2 | HRT FINANCIAL LP | 42,419 | $37.00 | 0.1% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Marex Group plc | ADD | 40,942 | 59,263 | +44.7% | $52.5K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 8 | 13 | +62.5% | $19.00 | 2025-Q4 |
| UBS Group AG | NEAR_EXIT | 5,653 | 801 | -85.8% | $2.3K | 2025-Q3 |
| UBS Group AG | TRIM | 94,298 | 54,808 | -41.9% | $19.0K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 51 | 68 | +33.3% | $24.00 | 2024-Q4 |
2 unique insiders with 2 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | Handley Michael K | Chief Executive Officer | EXERCISE | 2,206 | — | — |
| May 1, 2026 | Lackey Melinda | General Counsel & SVP of Legal | AWARD | 45,000 | — | — |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 4.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
57°
Neutral
Bearish
Neutral
Bullish
3 mentions
1 bullish
0 bearish
3 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 26, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 5, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 5, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
VBIO has fully funded government program.
▲ 1
💬 0
⚡ 0.5
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.